Riskpilot← Back to searchSign inGet full accessBIOXTRACTION AS
ASActiveOrg 829569132Ekebergveien 173, 1912 EnebakkEngineering activities and related technical consultancy · NACE 7112Est. 20220 employeeswww.bioxtraction.com
Revenue 2024
NOK 385K
EBITDA margin
-15.8%
+46% vs 2023
Equity ratio
94.6%
Financial strength
Net profit 2024
NOK -79K
+36% vs 2023
| Revenue | NOK 385K | — |
| EBITDA | NOK -61K | +46% |
| Net profit | NOK -79K | +36% |
| Total assets | NOK 1M | +530% |
| Equity | NOK 969K | +577% |
| Employees | 0 | — |
Legal name
BIOXTRACTION AS
Org number
829569132
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
29. juli 2022
Share capital
NOK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utvikling av nye industriprosesser for fremstilling og bearbeiding av plantemateriale, mikroalger og annen biomasse beregnet for næringsmidler generelt, samt fiskefor, dyrefor og kosttilskudd for salg i globalt marked. Selskapet vil kunne delta i andre selskaper, og annet som naturlig hører sammen.
Address
Ekebergveien 173, 1912 Enebakk
Website
www.bioxtraction.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 385 |
| Staff expenses | −0 | −0 | −188 |
| EBITDA | −58 | −113 | −61 |
| Depreciation & amort. | −0 | −11 | −18 |
| EBIT | −58 | −124 | −79 |
| Net financials | 0 | 0 | −0 |
| Profit before tax | −58 | −124 | −79 |
| Tax | −0 | −0 | −0 |
| Net profit | −58 | −124 | −79 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 268 | 163 | 1 024 |
| Equity | 267 | 143 | 969 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 1 | 20 | 55 |
| Total debt | 1 | 20 | 55 |
EBITDA margin
-15.8%
This company
15.8%
Market median
-200% vs market
20222024
Equity ratio
94.6%
This company
38.2%
Market median
+148% vs market
20222024
Return on equity
-8.2%
This company
18.4%
Market median
-145% vs market
20222024
Net profit margin
-20.6%
This company
8.1%
Market median
-354% vs market
20222024
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
20222024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
AA Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2025 | |
| Chairman | 2024 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 76.5% | 76.5% | 2022 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 17.5% | 17.5% | 2024 | |
| Company | 13.5% | 13.5% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOXTRACTION AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Adolfo Antonello Modesti Gonzalez | Chief Executive Officer | 0 companies |
| Sigve Jarl Sørensen | Chairman | 0 companies |
| Sunniva Sørensen | Chairman | 0 companies |
| Tyri Johanne Kvalvik | Board of Directors | 0 companies |
| Mikkel Somby | Board of Directors | 0 companies |